Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP — Stella

Home/Acquired Thrombotic Thrombocytopenic Purpura/

View on ClinicalTrials.gov

Recruiting

Back to Acquired Thrombotic Thrombocytopenic Purpura trials

Trial locations(1 site)

Germany

University Hospital of Cologne, Cologne

Key details

Sponsor

University of Cologne

Enrollment target

~350 participants

Started

March 2021

Primary completion

December 2034

Age range

18 Years and older

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.